The FDA's adverse event reporting system has received reports related to compounded GLP-1 medications involving dosing errors and other adverse events
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously a mechanism that sets it apart from existing agents such as semaglutide and tirzepatide
GLP-1 Visualization See patterns across medication, nutrition, hydration, and weightall in one place
Cost and Insurance Coverage Factor in your budget and insurance coverage when making a decision
For example, vitamin D is administered as an IM injection and vitamin C is given as an IV infusion
"This is a great place to get your IV, I have been here many times and it is very highly recommended, the people that work here are super nice and gentle" Maria V